Fig. 5From: Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trialsRanked perceptions of the private sector organisations on important barriers to adaptive designs (ADs) use in confirmatory trials. Red diamonds indicate barriers that were ranked higher by the private sector than UK Clinical Trials Units (CTUs). Blue squares indicate barriers that were ranked higher by the UK CTUs than the private sectorBack to article page